India eyes new pharma markets as US tariff risks loom large
Indian pharma stocks are in focus as the country prepares to expand exports to Russia, Brazil, and the Netherlands, reducing reliance on the US, which takes 35% of its drug shipments. While Indian pharma exports surged 20% to $10.5 billion in FY25, reports of possible US tariffs of up to 200% on medicines are raising investor concerns.